Zhejiang Anglikang Pharmaceutical (002940.SZ): Three products are expected to be selected for the 12th batch of centralized volume-based procurement.
Angelicon (002940.SZ) announced that recently, the company and its subsidiary Fujian Haixi United Pharmaceutical Co., Ltd. (hereinafter referred to as "Haixi Pharmaceutical") participated in the bidding work for the twelfth batch of national centralized procurement organized by the National Organization of Drug Centralized Procurement Office. According to the "Tentative Selection Results for the Twelfth Batch of National Centralized Procurement" (GY-YD2026-1) published by the National Organization of Drug Centralized Procurement Office on July 31, 2026, the company's sitagliptin metformin sustained-release tablets, sacubitril valsartan sodium tablets, and Haixi Pharmaceutical's inhaled isoflurane are proposed to be selected for the twelfth batch of centralized procurement.
Zhejiang Anglikang Pharmaceutical (002940.SZ) announced that recently, the company and its subsidiary Fujian Haixi United Pharmaceutical Co., Ltd. (hereinafter referred to as "Haixi Pharmaceutical") participated in the bidding organized by the National Joint Procurement Office for the 12th batch of national centralized drug procurement. According to the "Proposed Selection Results of the 12th Batch of National Centralized Drug Procurement" (GY-YD2026-1) released by the National Joint Procurement Office on July 31, 2026, the company's Sitagliptin Metformin Extended-Release Tablets, Sacubitril Valsartan Tablets, and Haixi Pharmaceutical's Inhalation Fluothane are proposed for selection in the 12th batch of centralized drug procurement.
The total sales revenue of these three proposed selected products for the year 2025 is approximately 50.68 million yuan, accounting for 3.56% of the company's total operating revenue for the year 2025.
Related Articles
Inner Mongolia BaoTou Steel Union (600010.SH): Report on the investigation of the 1.18 safety accident by the holding subsidiary has been released.
Guanglian Aviation Industry (300900.SZ) subsidiary won a bid for approximately 112 million yuan related to the CNOOC Energy Technology & Services tender project.
CASIN Real Estate Development Group (000838.SZ): The company faces uncertainty regarding the selection of investors for its pre-reorganization, and trading will be suspended starting August 3.
Inner Mongolia BaoTou Steel Union (600010.SH): Report on the investigation of the 1.18 safety accident by the holding subsidiary has been released.
Guanglian Aviation Industry (300900.SZ) subsidiary won a bid for approximately 112 million yuan related to the CNOOC Energy Technology & Services tender project.
CASIN Real Estate Development Group (000838.SZ): The company faces uncertainty regarding the selection of investors for its pre-reorganization, and trading will be suspended starting August 3.
RECOMMEND
